# FDA 483 - Auro Pharmacies, Inc. - August 12, 2022

Source: https://www.globalkeysolutions.net/records/483/auro-pharmacies-inc/7b6b482a-3f85-4bf5-a877-10d2f4596b02

> FDA 483 for Auro Pharmacies, Inc. on August 12, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Auro Pharmacies, Inc.
- Inspection Date: 2022-08-12
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: Auro Pharmacies, Inc. in La Habra, CA, a compounding pharmacy, was cited for two observations during an FDA inspection. The inspection revealed inadequate containment and cleaning practices for hazardous drug production, leading to potential cross-contamination. Additionally, non-microbial contamination, specifically white powder accumulation, was observed in production areas used for both hazardous and non-hazardous drug encapsulation.

## Related Documents

- [483 - 2018-08-02](https://www.globalkeysolutions.net/records/483/auro-pharmacies-inc/d1071938-c11e-4899-9b7f-a079d2450454)
- [STATE_REFERRAL_LETTER - 2022-08-08](https://www.globalkeysolutions.net/records/state_referral_letter/auro-pharmacies-inc/c4b4e72d-5026-44a3-8896-fafc83e84153)

## Related Officers

- [Pharmaceutical investigator](https://www.globalkeysolutions.net/people/bryan-a-galvez/d1e52abc-5b56-4ffb-af22-90e6733fb73a)

Company: https://www.globalkeysolutions.net/companies/auro-pharmacies-inc/25812b13-3828-4055-b6b7-6a62ae696c01

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6